ABOUT
A career built across science, innovation and public impact.
Geraldine Gueron is a molecular biologist, scientist, innovator, entrepreneur and public policy leader based in Buenos Aires.
She holds a degree in Biological Sciences and a PhD in Biological Chemistry from the University of Buenos Aires and is an Independent Researcher at CONICET. She leads the Inflammation and Cancer Laboratory at IQUIBICEN, UBA-CONICET, where her work focuses on molecular oncology, prostate cancer, biomarkers and precision medicine.
Her work has received international recognition from MIT Technology Review, the Prostate Cancer Foundation, the American Association for Cancer Research and Fulbright. She was a Fulbright Visiting Scholar at MD Anderson Cancer Center.
Her interest in taking science beyond the laboratory led her early to health data and digital innovation through Wikilife and, more recently, to co-found PreGen, a biotechnology company focused on molecular diagnostics and precision medicine.
Since 2025, she has served as Director General of Science and Technology for the City of Buenos Aires, working to strengthen the connection between scientific knowledge, innovation, entrepreneurship and economic development.
SELECTED JOURNEY
AACR Scholar-in-Training recognition and Prostate Cancer Foundation Young Investigator Award.
Early exploration of collaborative health data and digital health.
Selected by MIT Technology Review in Latin America.
Visiting Scholar in Oncology and Cancer Biology.
Appointed Director General of Science and Technology for the City of Buenos Aires.
Co-Founder & Chief Scientific Officer.